{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:53:50Z","timestamp":1769579630977,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FEDER funds throught the POCI-COMPETE 2020 - Operational Programme Competitiveness and Internationalisation in Axis I \u2013 Strengthening Research, Technological Development and Innovation","award":["POCI-01- 0145-FEDER-007491"],"award-info":[{"award-number":["POCI-01- 0145-FEDER-007491"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID \/ Multi \/ 00709\/2019"],"award-info":[{"award-number":["UID \/ Multi \/ 00709\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00216-019-02005-8","type":"journal-article","created":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T22:02:34Z","timestamp":1562796154000},"page":"6141-6153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Determination of antipsychotic drugs in oral fluid using dried saliva spots by gas chromatography-tandem mass spectrometry"],"prefix":"10.1007","volume":"411","author":[{"given":"D\u00e9bora","family":"Caramelo","sequence":"first","affiliation":[]},{"given":"Tiago","family":"Rosado","sequence":"additional","affiliation":[]},{"given":"Victor","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jesus M.","family":"Rodilla","sequence":"additional","affiliation":[]},{"given":"Pedro M. M.","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"M\u00e1rio","family":"Barroso","sequence":"additional","affiliation":[]},{"given":"Eugenia","family":"Gallardo","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,7,10]]},"reference":[{"key":"2005_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tips.2007.11.005","volume":"29","author":"P Mcguire","year":"2008","unstructured":"Mcguire P, Howes OD, Stone J, Fusar-poli P. Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci. 2008;29:91\u20138. \n                    https:\/\/doi.org\/10.1016\/j.tips.2007.11.005\n                    \n                  .","journal-title":"Trends Pharmacol Sci"},{"key":"2005_CR2","first-page":"1167","volume":"4","author":"M Mohammadi","year":"2001","unstructured":"Mohammadi M, Akhondzadeh S. Schizophrenia: etiology and pharmacotherapy. IDrugs. 2001;4:1167\u201372.","journal-title":"IDrugs"},{"key":"2005_CR3","doi-asserted-by":"publisher","first-page":"3953","DOI":"10.1007\/s00216-012-6695-y","volume":"405","author":"BM Da Fonseca","year":"2013","unstructured":"Da Fonseca BM, Moreno IED, Barroso M, Costa S, Queiroz JA, Gallardo E. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography \u2013 tandem mass spectrometry. Anal Bioanal Chem. 2013;405:3953\u201363. \n                    https:\/\/doi.org\/10.1007\/s00216-012-6695-y\n                    \n                  .","journal-title":"Anal Bioanal Chem"},{"key":"2005_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10:79\u2013104. \n                    https:\/\/doi.org\/10.1038\/sj.mp.4001556\n                    \n                  .","journal-title":"Mol Psychiatry"},{"key":"2005_CR5","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMra035458","volume":"349","author":"R Freedman","year":"2003","unstructured":"Freedman R. Schizophrenia. N Engl J Med. 2003;349:1738\u201349.","journal-title":"N Engl J Med"},{"key":"2005_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1373\/clinchem.2010.152124","volume":"57","author":"MA Huestis","year":"2011","unstructured":"Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clin Chem. 2011;57:805\u201310.","journal-title":"Clin Chem"},{"key":"2005_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.4155\/bio.09.23","volume":"1","author":"E Gallardo","year":"2009","unstructured":"Gallardo E, Barroso M, Queiroz JA. Current technologies and considerations for drug bioanalysis in oral fluid. Bioanalysis. 2009;1:637\u201367. \n                    https:\/\/doi.org\/10.4155\/bio.09.23\n                    \n                  .","journal-title":"Bioanalysis"},{"key":"2005_CR8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/bmc.1009","volume":"22","author":"E Gallardo","year":"2008","unstructured":"Gallardo E, Queiroz JA. The role of alternative specimens in toxicological analysis. Biomed Chromatogr. 2008;22:795\u2013821. \n                    https:\/\/doi.org\/10.1002\/bmc.1009\n                    \n                  .","journal-title":"Biomed Chromatogr"},{"key":"2005_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpba.2016.01.004","volume":"127","author":"A Petruczynik","year":"2016","unstructured":"Petruczynik A, Wr\u00f3blewski K, Szultka-M\u0142y\u0144ska M, Buszewski B, Karaku\u0142a-Juchnowicz H, Gajewski J, et al. Determination of some psychotropic drugs in serum and saliva samples by HPLC-DAD and HPLC MS. J Pharm Biomed Anal. 2016;127:68\u201380. \n                    https:\/\/doi.org\/10.1016\/j.jpba.2016.01.004\n                    \n                  .","journal-title":"J Pharm Biomed Anal"},{"key":"2005_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.forsciint.2013.02.010","volume":"229","author":"DS Fisher","year":"2013","unstructured":"Fisher DS, Partridge SJ, Handley SA, Couchman L, Morgan PE, Flanagan RJ. LC\u2013MS\/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood. Forensic Sci Int. 2013;229:145\u201350. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2013.02.010\n                    \n                  .","journal-title":"Forensic Sci Int"},{"key":"2005_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/FTD.0000000000000242","volume":"38","author":"L Patteet","year":"2016","unstructured":"Patteet L, Maudens KE, Morrens M, Sabbe B, Dom G, Neels H. Determination of common antipsychotics in quantisal-collected oral fluid by UHPLC-MS\/MS: method validation and applicability for therapeutic drug monitoring. Ther Drug Monit. 2016;38:87\u201397. \n                    https:\/\/doi.org\/10.1097\/FTD.0000000000000242\n                    \n                  .","journal-title":"Ther Drug Monit"},{"key":"2005_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jchromb.2013.01.025","volume":"927","author":"D Di Corcia","year":"2013","unstructured":"Di Corcia D, Lisi S, Pirro V, Gerace E, Salomone A, Vincenti M. Determination of pharmaceutical and illicit drugs in oral fluid by ultra-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B. 2013;927:133\u201341. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2013.01.025\n                    \n                  .","journal-title":"J Chromatogr B"},{"key":"2005_CR13","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.talanta.2010.02.067","volume":"81","author":"MA Saracino","year":"2010","unstructured":"Saracino MA, De Palma A, Boncompagni G, Raggi MA. Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedure. Talanta. 2010;81:1547\u201353. \n                    https:\/\/doi.org\/10.1016\/j.talanta.2010.02.067\n                    \n                  .","journal-title":"Talanta"},{"key":"2005_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.trac.2016.07.010","volume":"83","author":"H Elmongy","year":"2016","unstructured":"Elmongy H, Abdel-Rehim M. Saliva as an alternative specimen to plasma for drug bioanalysis: a review. Trends Anal Chem. 2016;83:70\u20139. \n                    https:\/\/doi.org\/10.1016\/j.trac.2016.07.010\n                    \n                  .","journal-title":"Trends Anal Chem"},{"key":"2005_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/FTD.0000000000000493","volume":"40","author":"J Neumann","year":"2018","unstructured":"Neumann J, Beck O, Dahmen N, B\u00f6ttcher M. Potential of oral fluid as a clinical specimen for compliance monitoring of psychopharmacotherapy. Ther Drug Monit. 2018;40:245\u201351.","journal-title":"Ther Drug Monit"},{"key":"2005_CR16","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.4155\/bio.11.270","volume":"3","author":"P Abu-Rabie","year":"2011","unstructured":"Abu-Rabie P, Spooner N. Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis. Bioanalysis. 2011;3:2769\u201381. \n                    https:\/\/doi.org\/10.4155\/bio.11.270\n                    \n                  .","journal-title":"Bioanalysis"},{"key":"2005_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/bmc.3193","volume":"28","author":"A Abdel-Rehim","year":"2014","unstructured":"Abdel-Rehim A, Abdel-Rehim M. Dried saliva spot as a sampling technique for saliva samples. Biomed Chromatogr. 2014;28:875\u20137. \n                    https:\/\/doi.org\/10.1002\/bmc.3193\n                    \n                  .","journal-title":"Biomed Chromatogr"},{"key":"2005_CR18","doi-asserted-by":"publisher","unstructured":"Carvalho J, Rosado T, Barroso M, Gallardo E, Investiga\u00e7\u00e3o C De, Interior B, D AI, F\u00e1rmaco-toxicologia L De, Beira U. Determination of antiepileptic drugs using dried saliva spots. J Anal Toxicol. 2018:1\u201311. \n                    https:\/\/doi.org\/10.1093\/jat\/bky064\n                    \n                  .","DOI":"10.1093\/jat\/bky064"},{"key":"2005_CR19","doi-asserted-by":"publisher","unstructured":"Ribeiro A, Prata M, Vaz C, Rosado T, Restolho J, Barroso M, et al. Determination of methadone and EDDP in oral fluid using the dried saliva spots sampling approach and gas chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2019:1\u201311. \n                    https:\/\/doi.org\/10.1007\/s00216-019-01654-z\n                    \n                  .","DOI":"10.1007\/s00216-019-01654-z"},{"key":"2005_CR20","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1021\/acs.analchem.5b04059","volume":"88","author":"M Numako","year":"2015","unstructured":"Numako M, Takayama T, Noge I, Kitagawa Y, Todoroki K, et al. Dried saliva spot (DSS) as a convenient and reliable sampling for bioanalysis: an application for the diagnosis of diabetes mellitus. Anal Chem. 2015;88:635\u20139. \n                    https:\/\/doi.org\/10.1021\/acs.analchem.5b04059\n                    \n                  .","journal-title":"Anal Chem"},{"key":"2005_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jpba.2017.04.032","volume":"142","author":"X Chen","year":"2017","unstructured":"Chen X, Zheng S, Le J, Qian Z, Zhang R, Hong Z, et al. Ultrasound-assisted low-density solvent dispersive liquid\u2013liquid microextraction for the simultaneous determination of 12 new antidepressants and 2 antipsychotics in whole blood by gas chromatography\u2013mass spectrometry. J Pharm Biomed Anal. 2017;142:19\u201327. \n                    https:\/\/doi.org\/10.1016\/j.jpba.2017.04.032\n                    \n                  .","journal-title":"J Pharm Biomed Anal"},{"key":"2005_CR22","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/rcm.8087","volume":"32","author":"T Rosado","year":"2018","unstructured":"Rosado T, Oppolzer D, Cruz B, Barroso M, Varela S, Oliveira V, et al. Development and validation of a gas chromatography\/tandem mass spectrometry method for simultaneous quantitation of several antipsychotics in human plasma and oral fluid. Rapid Commun Mass Spectrom. 2018;32:2081\u201395. \n                    https:\/\/doi.org\/10.1002\/rcm.8087\n                    \n                  .","journal-title":"Rapid Commun Mass Spectrom"},{"key":"2005_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.talanta.2019.01.112","volume":"198","author":"D Koller","year":"2019","unstructured":"Koller D, Zubiaur P, Saiz-Rodr\u00edguez M, Abad-Santos F, Wojnicz A. Simultaneous determination of six antipsychotics, two of their metabolites and caffeine in human plasma by LC-MS\/MS using a phospholipid-removal microelution-solid phase extraction method for sample preparation. Talanta. 2019;198:159\u201368. \n                    https:\/\/doi.org\/10.1016\/j.talanta.2019.01.112\n                    \n                  .","journal-title":"Talanta"},{"key":"2005_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cca.2014.12.008","volume":"441","author":"L Patteet","year":"2015","unstructured":"Patteet L, Cappelle D, Maudens KE, Crunelle CL, Sabbe B, Neels H. Advances in detection of antipsychotics in biological matrices. Clin Chim Acta. 2015;441:11\u201322. \n                    https:\/\/doi.org\/10.1016\/j.cca.2014.12.008\n                    \n                  .","journal-title":"Clin Chim Acta"},{"key":"2005_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5807218","volume":"2018","author":"A Khelfi","year":"2018","unstructured":"Khelfi A, Azzouz M, Abtroun R, Reggabi M, Alamir B. Determination of chlorpromazine, haloperidol, levomepromazine, olanzapine, risperidone, and sulpiride in human plasma by liquid chromatography\/tandem mass spectrometry (LC-MS\/MS). Int J Anal Chem. 2018;2018:1\u201313. \n                    https:\/\/doi.org\/10.1155\/2018\/5807218\n                    \n                  .","journal-title":"Int J Anal Chem"},{"key":"2005_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.forsciint.2009.12.027","volume":"196","author":"MK Nielsen","year":"2010","unstructured":"Nielsen MK, Johansen SS, Dalsgaard PW, Linnet K. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC\u2013TOF-MS. Forensic Sci Int. 2010;196:85\u201392. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2009.12.027\n                    \n                  .","journal-title":"Forensic Sci Int"},{"key":"2005_CR27","unstructured":"Food and Drug Administration, Bioanalytical Method Validation Guidance for Industry, (2018)\n                    http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm\n                    \n                   (accessed 4 Feb 2019)."},{"key":"2005_CR28","unstructured":"International Conference on Harmonisation (1996) Validation of analytical procedures: text and methodology Q2 (R1). Int Conf Harmon 11\u201312 . doi: \n                    http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Quality\/Q2_R1\/Step4\/Q2_R1__Guideline.pdf\n                    \n                   accessed 4 Feb 2019)."},{"key":"2005_CR29","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jat\/bkt054","volume":"37","author":"Scientific Working Group for Forensic Toxicology (SWGTOX)","year":"2013","unstructured":"Scientific Working Group for Forensic Toxicology (SWGTOX). Standard practices for method validation in forensic toxicology. J Anal Toxicol. 2013;37:452\u201374.","journal-title":"J Anal Toxicol"},{"key":"2005_CR30","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.4155\/bio.11.132","volume":"3","author":"P Timmerman","year":"2011","unstructured":"Timmerman P, White S, Globig S, et al. EBF recommendation on the validation of bioanalytical methods for dried blood spots. Bioanalysis. 2011;3:1567\u201375.","journal-title":"Bioanalysis"},{"key":"2005_CR31","doi-asserted-by":"publisher","first-page":"8779","DOI":"10.1021\/ac202321q","volume":"83","author":"P Abu-Rabie","year":"2011","unstructured":"Abu-Rabie P, Denniff P, Spooner N, Brynjolffssen J, Galluzzo P, Sanders G. Method of applying internal standard to dried matrix spot samples for use in quantitative bioanalysis. Anal Chem. 2011;83:8779\u201386. \n                    https:\/\/doi.org\/10.1021\/ac202321q\n                    \n                  .","journal-title":"Anal Chem"},{"key":"2005_CR32","doi-asserted-by":"publisher","first-page":"E109","DOI":"10.1208\/aapsj0901011","volume":"9","author":"S Bansal","year":"2007","unstructured":"Bansal S, DeStefano A. Key elements of bioanalytical method validation for small molecules. AAPS J. 2007;9:E109\u201314. \n                    https:\/\/doi.org\/10.1208\/aapsj0902017\n                    \n                  .","journal-title":"AAPS J"},{"key":"2005_CR33","unstructured":"World Anti-doping Agency, International standard for laboratories: identification criteria for qualitative assays incorporating column chromatography and mass spectrometry, (2010). \n                    https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA_TD2010IDCRv1.0_Identification%20Criteria%20for%20Qualitative%20Assays_May%2008%202010_EN.doc.pdf\n                    \n                   (accessed 6 Jan 2019)."},{"key":"2005_CR34","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jpba.2007.02.022","volume":"44","author":"M Pujadas","year":"2007","unstructured":"Pujadas M, Pichini S, Civit E, Santamari\u00f1a E, Perez K, de la Torre R. A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry. J Pharm Biomed Anal. 2007;44:594\u2013601. \n                    https:\/\/doi.org\/10.1016\/j.jpba.2007.02.022\n                    \n                  .","journal-title":"J Pharm Biomed Anal"},{"key":"2005_CR35","doi-asserted-by":"crossref","unstructured":"De Bi\u00e8vre P, G\u00fcnzler H. Validation in chemical measurement. 1st edition. Berlin: Springer-Verlag Berlin Heidelberg; 2005.","DOI":"10.1007\/b138530"},{"key":"2005_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/FTD.0b013e318283eaf2","volume":"35","author":"DS Fisher","year":"2013","unstructured":"Fisher DS, van Schalkwyk GI, Seedat S, Curran SR, Flanagan RJ. Plasma, oral fluid, and whole-blood distribution of antipsychotics and metabolites in clinical samples. Ther Drug Monit. 2013;35:345\u201351.","journal-title":"Ther Drug Monit"},{"key":"2005_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jchromb.2011.02.027","volume":"879","author":"K Langel","year":"2011","unstructured":"Langel K, Gunnar T, Ariniemi K, Rajam\u00e4ki O, Lillsunde P. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography\u2013mass spectrometry. J Chromatogr B. 2011;879:859\u201370.","journal-title":"J Chromatogr B"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-02005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-019-02005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-019-02005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T23:07:13Z","timestamp":1594249633000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-019-02005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,10]]},"references-count":37,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2005"],"URL":"https:\/\/doi.org\/10.1007\/s00216-019-02005-8","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,10]]},"assertion":[{"value":"7 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The present study was approved by the ethics committee from Centro Hospitalar Cova da Beira and has been conducted according to ethical standards. The analyzed authentic samples belonged to individuals who provided an informed consent for their use, and all analyses were carried out according to the ethical standards of the institution.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}